Timothy Cloughsey

机构：University of California, Los Angeles

发表论文 12 篇 · 总被引 89 次 · h-index 5

代表论文

A novel treatment for glioblastoma: integrin inhibition (2012 · Expert Review of Neurotherapeutics · 被引 35)
Phase II study of AMG 102, a fully human neutralizing antibody against hepatocyte growth factor/scatter factor, in patients with recurrent glioblastoma multiforme (2008 · Journal of Clinical Oncology · 被引 24)
Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio (PL02.002) (2013 · Neurology · 被引 13)
NEURO/MEDICAL ONCOLOGY (2013 · Neuro-Oncology · 被引 8)
FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (2013 · Neuro-Oncology · 被引 5)
Image registration and modeling of Ga-68 EDTA for determination of BBB permeability changes induced by pharmacological intervention (RMP7) in tumor patients (1996 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 被引 3)